Tyenne 20 mg/mL concentrate for solution for infusion

Company
Fresenius Kabi Ltd
Active Ingredient
Dosage Form
Concentrate for solution for infusion
Legal Category
A - prescription, may not be renewed
Date of revision
08/2026

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/23/1754/001 20 mg/ml L04AC07 Concentrate for solution for infusion
EU/1/23/1754/002 20 mg/ml L04AC07 Concentrate for solution for infusion
EU/1/23/1754/003 20 mg/ml L04AC07 Concentrate for solution for infusion
EU/1/23/1754/004 20 mg/ml L04AC07 Concentrate for solution for infusion
EU/1/23/1754/005 20 mg/ml L04AC07 Concentrate for solution for infusion
EU/1/23/1754/006 20 mg/ml L04AC07 Concentrate for solution for infusion
Licence number
EU/1/23/1754/001
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/002
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/003
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/004
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/005
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/23/1754/006
Strength
20 mg/ml
ATC Code
L04AC07
Dosage Form
Concentrate for solution for infusion

Fresenius Kabi Ltd

Unit 3B Fingal Bay Business Park, Balbriggan, Co. Dublin, Ireland, K32YK12

Website
https://www.fresenius-kabi.com/ie
Telephone
+35318413030
Email
Medical.Information-uk@fresenius-kabi.com